The relation between Panx1 in LECs and atherosclerosis may however go beyond quantitative changes in lymphatic vessel number and further experiments focused on the implications of LEC-specific Panx1 deletion on atherosclerotic plaque burden and stability during the initiation phase as well as during the progression of the disease. Here, PANX1 is linked to atherosclerosis.